Stockreport

Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF April 2, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral n [Read more]